Telemedicine

Pediatric Retina: Second Edition

Volumn , Issue , 2013, Pages

  Moshfeghi, Darius M ^a,b   Capone, Antonio ^c,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNDROP Telemedicine Network   (United States)

^c OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973912624     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (82)

1. Steinkuller PG, Du L, Gilbert C, et al. Childhood blindness. J AAPOS 1999;3:26-32.
2. Repka MX. Ophthalmological problems of the premature infant. Ment Retard Dev Disabil Res Rev 2002;8:249-257.
3. O'Connor AR, Fielder AR. Visual outcomes and perinatal adversity. Semin Fetal Neonatal Med 2007;12:408-414.
4. O'Connor AR, Wilson CM, Fielder AR. Ophthalmological problems associated with preterm birth. Eye (Lond) 2007;21:1254-1260.
5. Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1990;108:195-204.
6. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1990;108:1408-1416.
7. McNamara JA, Tasman W, Brown GC, et al. Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmology 1991;98:576-580.
8. Capone A Jr, Diaz-Rohena R, Sternberg P Jr, et al. Diode-laser photocoagulation for zone 1 threshold retinopathy of prematurity. Am J Ophthalmol 1993;116:444-450.
9. Hunter DG, Repka MX. Diode laser photocoagulation for threshold retinopathy of prematurity. A randomized study. Ophthalmology 1993;100:238-244.
10. Banach MJ, Ferrone PJ, Trese MT. A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity. Ophthalmology 2000;107:324-327; discussion 328.
11. Early Treatment For Retinopathy Of Prematurity Cooperative G. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684-1694.
12. Rezai KA, Eliott D, Ferrone PJ, et al. Near confluent laser photocoagulation for the treatment of threshold retinopathy of prematurity. Arch Ophthalmol 2005;123:621-626.
13. Drenser KA, Trese MT, Capone A Jr. Aggressive posterior retinopathy of prematurity. Retina 2010;30:S37-S40.
14. Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011;364:603-615.
15. Screening examination of premature infants for retinopathy of prematurity. A joint statement of the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, and the American Academy of Ophthalmology. Pediatrics 1997;100:273.
16. Section on Ophthalmology American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2001;108:809-811.
17. American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013;131:189.
18. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984;102:1130-1134.
19. An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. Arch Ophthalmol 1987;105:906-912.
20. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005;123:991-999.
21. Day S, Menke AM, Abbott RL. Retinopathy of prematurity malpractice claims: the Ophthalmic Mutual Insurance Company experience. Arch Ophthalmol 2009;127:794-798.
22. Reynolds JD. Malpractice and the quality of care in retinopathy of prematurity (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2007;105:461-480.
23. Attar MA, Gates MR, Iatrow AM, et al. Barriers to screening infants for retinopathy of prematurity after discharge or transfer from a neonatal intensive care unit. J Perinatol 2005;25:36-40.
24. Kemper AR, Wallace DK. Neonatologists' practices and experiences in arranging retinopathy of prematurity screening services. Pediatrics 2007;120:527-531.
25. Demorest BH. Retinopathy of prematurity requires diligent follow-up care. Surv Ophthalmol 1996;41:175-178.
26. Reynolds JD, Dobson V, Quinn GE, et al. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 2002;120:1470-1476.
27. Brader HS, Ying GS, Martin ER, et al. New grading criteria allow for earlier detection of geographic atrophy in clinical trials. Invest Ophthalmol Vis Sci 2011;52:9218-9225.
28. Friedman SM, Margo CE. Choroidal neovascular membranes: reproducibility of angiographic interpretation. Am J Ophthalmol 2000;130:839-841.
29. Holz FG, Jorzik J, Schutt F, et al. Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study). Ophthalmology 2003;110:400-405.
30. Hutchinson A, McIntosh A, Peters J, et al. Effectiveness of screening and monitoring tests for diabetic retinopathy-a systematic review. Diabet Med 2000;17:495-506.
31. Kaiser RS, Berger JW, Williams GA, et al. Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration. Retina 2002;22:683-690.
32. Maberley DA, Isbister C, Mackenzie P, et al. An evaluation of photographic screening for neovascular age-related macular degeneration. Eye (Lond) 2005;19:611-616.
33. Milton RC, Ganley JP, Lynk RH. Variability in grading diabetic retinopathy from stereo fundus photographs: comparison of physician and lay readers. Br J Ophthalmol 1977;61:192-201.
34. Moss SE, Klein R, Kessler SD, et al. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology 1985;92:62-67.
35. Muni RH, Altaweel M, Tennant M, et al. Agreement among Canadian retina specialists in the determination of treatment eligibility for photodynamic therapy in age-related macular degeneration. Retina 2008;28:1421-1426.
36. Tugal-Tutkun I, Herbort CP, Khairallah M, et al. Interobserver agreement in scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation. Ocul Immunol Inflamm 2010;18:385-389.
37. Vujosevic S, Vaclavik V, Bird AC, et al. Combined grading for choroidal neovascularisation: colour, fluorescein angiography and autofluorescence images. Graefes Arch Clin Exp Ophthalmol 2007;245:1453-1460.
38. Wilson PJ, Ellis JD, MacEwen CJ, et al. Screening for diabetic retinopathy: a comparative trial of photography and scanning laser ophthalmoscopy. Ophthalmologica 2010;224:251-257.
39. Kemper AR, Freedman SF, Wallace DK. Retinopathy of prematurity care: patterns of care and workforce analysis. J AAPOS 2008;12:344-348.
40. Myung JS, Paul Chan RV, Espiritu MJ, et al. Accuracy of retinopathy of prematurity image-based diagnosis by pediatric ophthalmology fellows: implications for training. J AAPOS 2011;15:573-578.
41. Wallace DK. Fellowship training in retinopathy of prematurity. J AAPOS 2012;16:1.
42. Paul Chan RV, Williams SL, Yonekawa Y, et al. Accuracy of retinopathy of prematurity diagnosis by retinal fellows. Retina 2010;30:958-965.
43. Roach L. ROP crisis near, survey says. News in review. EyeNet July 2006.
44. Lad EM, Hernandez-Boussard T, Morton JM, et al. Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am J Ophthalmol 2009;148:451-458.
45. Lad EM, Nguyen TC, Morton JM, et al. Retinopathy of prematurity in the United States. Br J Ophthalmol 2008;92: 320-325.
46. Lorenz B, Bock M, Muller HM, et al. Telemedicine based screening of infants at risk for retinopathy of prematurity. Stud Health Technol Inform 1999;64:155-163.
47. Schwartz SD, Harrison SA, Ferrone PJ, et al. Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology 2000;107:25-28.
48. Yen KG, Hess D, Burke B, et al. Telephotoscreening to detect retinopathy of prematurity: preliminary study of the optimum time to employ digital fundus camera imaging to detect ROP. J AAPOS 2002;6:64-70.
49. Ells AL, Holmes JM, Astle WF, et al. Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study. Ophthalmology 2003;110:2113-2117.
50. Chiang MF, Keenan JD, Du YE, et al. Assessment of image-based technology: impact of referral cutoff on accuracy and reliability of remote retinopathy of prematurity diagnosis. AMIA Annu Symp Proc 2005;2005:126-130.
51. Chiang MF, Starren J, Du YE, et al. Remote image based retinopathy of prematurity diagnosis: a receiver operating characteristic analysis of accuracy. Br J Ophthalmol 2006;90:1292-1296.
52. Chiang MF, Jiang L, Gelman R, et al. Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol 2007;125:875-880.
53. Chiang MF, Wang L, Busuioc M, et al. Telemedical retinopathy of prematurity diagnosis: accuracy, reliability, and image quality. Arch Ophthalmol 2007;125:1531-1538.
54. Lajoie A, Koreen S, Wang L, et al. Retinopathy of prematurity management using single-image vs multiple-image telemedicine examinations. Am J Ophthalmol 2008;146:298-309.
55. Murakami Y, Jain A, Silva RA, et al. Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 12-month experience with telemedicine screening. Br J Ophthalmol 2008;92:1456-1460.
56. Scott KE, Kim DY, Wang L, et al. Telemedical diagnosis of retinopathy of prematurity intraphysician agreement between ophthalmoscopic examination and image-based interpretation. Ophthalmology 2008;115:1222-1228 e3.
57. Chiang MF, Gelman R, Martinez-Perez ME, et al. Image analysis for retinopathy of prematurity diagnosis. J AAPOS 2009;13:438-445.
58. Lorenz B, Spasovska K, Elflein H, et al. Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study. Graefes Arch Clin Exp Ophthalmol 2009;247:1251-1262.
59. Richter GM, Sun G, Lee TC, et al. Speed of telemedicine vs ophthalmoscopy for retinopathy of prematurity diagnosis. Am J Ophthalmol 2009;148:136-142 e2.
60. Richter GM, Williams SL, Starren J, et al. Telemedicine for retinopathy of prematurity diagnosis: evaluation and challenges. Surv Ophthalmol 2009;54:671-685.
61. Silva RA, Murakami Y, Jain A, et al. Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 18-month experience with telemedicine screening. Graefes Arch Clin Exp Ophthalmol 2009;247:129-136.
62. Lee JY, Du YE, Coki O, et al. Parental perceptions toward digital imaging and telemedicine for retinopathy of prematurity management. Graefes Arch Clin Exp Ophthalmol 2010;248:141-147.
63. Murakami Y, Silva RA, Jain A, et al. Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 24-month experience with telemedicine screening. Acta Ophthalmol 2010;88:317-322.
64. Williams SL, Wang L, Kane SA, et al. Telemedical diagnosis of retinopathy of prematurity: accuracy of expert versus non-expert graders. Br J Ophthalmol 2010;94:351-356.
65. Dai S, Chow K, Vincent A. Efficacy of wide-field digital retinal imaging for retinopathy of prematurity screening. Clin Experiment Ophthalmol 2011;39:23-29.
66. Silva RA, Murakami Y, Lad EM, et al. Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 36-month experience with telemedicine screening. Ophthalmic Surg Lasers Imaging 2011;42:12-19.
67. Wittenberg LA, Jonsson NJ, Paul Chan RV, et al. Computer-based image analysis for plus disease diagnosis in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2012;49:11-19.
68. Photographic Screening for Retinopathy of Prematurity (Photo-ROP) Cooperative Group. The photographic screening for retinopathy of prematurity study (photo-ROP). Primary outcomes. Retina 2008;28:S47-S54.
69. Wu C, Petersen RA, VanderVeen DK. RetCam imaging for retinopathy of prematurity screening. J AAPOS 2006;10:107-111.
70. Roth DB, Morales D, Feuer WJ, et al. Screening for retinopathy of prematurity employing the retcam 120: sensitivity and specificity. Arch Ophthalmol 2001;119:268-272.
71. Dhaliwal C, Wright E, Graham C, et al. Wide-field digital retinal imaging versus binocular indirect ophthalmoscopy for retinopathy of prematurity screening: a two-observer prospective, randomised comparison. Br J Ophthalmol 2009;93:355-359.
72. Balasubramanian M, Capone A Jr, Hartnett ME, et al. The Photographic Screening for Retinopathy of Prematurity Study (Photo-ROP): study design and baseline characteristics of enrolled patients. Retina 2006;26:S4-S10.
73. Chiang MF, Melia M, Buffenn AN, et al. Detection of clinically significant retinopathy of prematurity using wide-angle digital retinal photography: a report by the American Academy of Ophthalmology. Ophthalmology 2012;119(6):1272-1280.
74. Wallace DK, Zhao Z, Freedman SF. A pilot study using "ROPtool" to quantify plus disease in retinopathy of prematurity. J AAPOS 2007;11:381-387.
75. Wallace DK, Veness-Meehan KA, Miller WC. Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels. J AAPOS 2007;11:170-174.
76. Wallace DK, Quinn GE, Freedman SF, et al. Agreement among pediatric ophthalmologists in diagnosing plus and pre-plus disease in retinopathy of prematurity. J AAPOS 2008;12:352-356.
77. Wallace DK, Jomier J, Aylward SR, et al. Computer-automated quantification of plus disease in retinopathy of prematurity. J AAPOS 2003;7:126-130.
78. Wallace DK, Freedman SF, Zhao Z, et al. Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity. Arch Ophthalmol 2007;125:1523-1530.
79. Wallace DK, Freedman SF, Zhao Z. A pilot study using ROPtool to measure retinal vascular dilation. Retina 2009;29:1182-1187.
80. Wallace DK, Freedman SF, Zhao Z. Evolution of plus disease in retinopathy of prematurity: quantification by ROP tool. Trans Am Ophthalmol Soc 2009;107:47-52.
81. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Pediatrics 1988;81:697-706.
82. Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 2005;115:e518-e525.